The new ceo of abvc biopharma takes steps to help improve cash efficiency

Fremont, ca, july 06, 2023 (globe newswire) -- via newmediawire - abvc biopharma, inc. (nasdaq: abvc) ("company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, cns, and ophthalmology, today announced the visionary new ceo of abvc has selflessly chosen to forgo a salary, instead opting for stock options as a pivotal component of his compensation package.
ABVC Ratings Summary
ABVC Quant Ranking